GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Rating:
Mkt Perform
MDVN

MEDIVATION INC (MDVN) rated Mkt Perform by Bernstein

Posted on: Monday,  Feb 3, 2014  9:25 AM ET by Bernstein

MEDIVATION INC (NASDAQ:
MDVN) rated Mkt Perform by Bernstein.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2014 9:25 AM Hold
None
77.03
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy